Drug Interaction Report

Acarbose and Insulin Lispro, Recombinant: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Acarbose

Prandase® Precose Precose®
+

Insulin Lispro, Recombinant

Admelog Humalog Lyumjev
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 10, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 135 documented Acarbose interactions, 70 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Taking acarbose with insulin lispro can add up to lower your blood sugar too much, so your insulin dose may need adjusting and your sugar watched more closely. If you have low blood sugar, treat it with glucose tablets rather than table sugar.

Both of these medicines lower your blood sugar, just in different ways. Insulin lispro (Humalog, Admelog, Lyumjev) directly brings your sugar down, while acarbose (Precose) slows how fast you absorb sugar from meals. When you take them together, their effects add up, and your blood sugar can drop too low. This is called hypoglycemia.

Signs of low blood sugar include shakiness, sweating, dizziness, confusion, or feeling very hungry. The good news is this is very manageable. Your care team may lower your insulin dose and watch your numbers a little more closely. Keep taking both as prescribed, and check with your doctor or pharmacist before making any changes.

Effect: Additive pharmacodynamic hypoglycemia when acarbose is combined with insulin lispro.

  • Mechanism: Additive glucose-lowering (PD). Acarbose is an alpha-glucosidase inhibitor delaying carbohydrate absorption; insulin lispro is a rapid-acting insulin. No CYP prodrug activation involved.
  • Direction/magnitude: Increased hypoglycemia risk; magnitude not quantified.
  • Onset: Unspecified.
  • Evidence: Theoretical.
  • Management: Insulin dose may need reduction and individualization; monitor blood glucose more frequently. Note: acarbose delays sucrose hydrolysis, so treat any hypoglycemic episode with oral glucose (dextrose), not table sugar.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of hypoglycemia

Interaction Deep Dive

When oral antidiabetic drugs are given together with insulin 1 or pramlintide 2, glucose metabolism can be affected, potentially raising the likelihood of hypoglycemia. A reduction in the insulin dose may be required if it is combined with oral antidiabetic agents 3.

Why it happens (mechanism)

Altered glucose metabolism; additive hypoglycemia

How to manage this interaction

This interaction is manageable with a few practical steps:

  • Keep taking both exactly as prescribed unless your care team tells you otherwise.
  • Your insulin dose may be adjusted and individualized by your care team, and they may monitor your blood sugar more closely.
  • Monitor for low blood sugar symptoms (shakiness, sweating, confusion, hunger).
  • Important: because acarbose slows sugar absorption, treat any low blood sugar with glucose tablets or gel, not table sugar or juice.

Raise any low readings or symptoms with your pharmacist or prescriber so they can fine-tune your plan.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Acarbose and Insulin Lispro, Recombinant together?

Taking acarbose with insulin lispro can add up to lower your blood sugar too much, so your insulin dose may need adjusting and your sugar watched more closely. If you have low blood sugar, treat it with glucose tablets rather than table sugar. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Acarbose and Insulin Lispro, Recombinant interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Acarbose and Insulin Lispro, Recombinant interaction managed?

This interaction is manageable with a few practical steps: Keep taking both exactly as prescribed unless your care team tells you otherwise. Your insulin dose may be adjusted and individualized by your care team, and they may monitor your blood sugar more closely. Monitor for low blood sugar symptoms (shakiness, sweating, confusion, hunger). Important: because acarbose slows sugar absorption, trea… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Acarbose or Insulin Lispro, Recombinant need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: Tresiba subcutaneous injection solution, insulin degludec subcutaneous injection solution. Novo Nordisk A/S (per EMA), Bagsvaerd, Denmark, 2013. DailyMed
  2. Product Information: SYMLIN(R) subcutaneous injection, pramlintide acetate subcutaneous injection. AstraZeneca Pharmaceuticals LP (per manufacturer), Wilmington, DE, 2016. DailyMed
  3. Product Information: GLYXAMBI(R) oral tablets, empagliflozin linagliptin oral tablets. Boehringer Ingelheim Pharmaceuticals Inc (per manufacturer), Ridgefield, CT, 2019. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.